Transpek Industry (506687) 주식 개요트랜스펙 인더스트리 리미티드는 인도에서 화학 제품을 제조 및 판매하는 회사입니다. 자세히 보기506687 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적1/6재무 건전성6/6배당5/6강점주가수익률(11.9x)이 Indian 시장(23x)보다 낮습니다.위험 분석지난 5년간 매년 수익이 1.8% 감소했습니다.의미 있는 시가총액이 없습니다(₹5B)불안정한 배당 실적모든 위험 점검 보기506687 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹975.0548.2% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture08b2016201920222025202620282031Revenue ₹7.7bEarnings ₹567.1mAdvancedSet Fair ValueView all narrativesTranspek Industry Limited 경쟁사Keltech EnergiesSymbol: BSE:506528Market cap: ₹5.2bPrimo ChemicalsSymbol: BSE:506852Market cap: ₹5.9bNahar Poly FilmsSymbol: BSE:523391Market cap: ₹5.9bPetro Carbon and ChemicalsSymbol: NSEI:PCCLMarket cap: ₹6.9b가격 이력 및 성과Transpek Industry 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가₹975.0552주 최고가₹1,817.9552주 최저가₹864.00베타0.121개월 변동-19.19%3개월 변동6.77%1년 변동-42.83%3년 변동-54.53%5년 변동-42.16%IPO 이후 변동200.02%최근 뉴스 및 업데이트Valuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹999, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.공시 • May 27Transpek Industry Limited Recommends Dividend for the Year Ended March 31, 2026Transpek Industry Limited at the board meeting held on May 26, 2026 recommended and approved the dividend of INR 20/- (200%) per equity share on the face value of INR 10/- each for the year ended March 31, 2026, which shall be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days of its declaration by the shareholders at the AGM to be held on September 15, 2026.New Risk • May 27New major risk - Revenue and earnings growthEarnings have declined by 1.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.8% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹5.99b market cap, or US$62.5m).공시 • May 18Transpek Industry Limited to Report Q4, 2026 Results on May 26, 2026Transpek Industry Limited announced that they will report Q4, 2026 results on May 26, 2026Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,056, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 32% over the past three years.Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: ₹19.42 (vs ₹19.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹19.42 (up from ₹19.06 in 3Q 2025). Revenue: ₹1.62b (down 4.7% from 3Q 2025). Net income: ₹108.5m (up 2.3% from 3Q 2025). Profit margin: 6.7% (up from 6.2% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 10% per year.더 많은 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹999, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.공시 • May 27Transpek Industry Limited Recommends Dividend for the Year Ended March 31, 2026Transpek Industry Limited at the board meeting held on May 26, 2026 recommended and approved the dividend of INR 20/- (200%) per equity share on the face value of INR 10/- each for the year ended March 31, 2026, which shall be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days of its declaration by the shareholders at the AGM to be held on September 15, 2026.New Risk • May 27New major risk - Revenue and earnings growthEarnings have declined by 1.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.8% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹5.99b market cap, or US$62.5m).공시 • May 18Transpek Industry Limited to Report Q4, 2026 Results on May 26, 2026Transpek Industry Limited announced that they will report Q4, 2026 results on May 26, 2026Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,056, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 32% over the past three years.Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: ₹19.42 (vs ₹19.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹19.42 (up from ₹19.06 in 3Q 2025). Revenue: ₹1.62b (down 4.7% from 3Q 2025). Net income: ₹108.5m (up 2.3% from 3Q 2025). Profit margin: 6.7% (up from 6.2% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 10% per year.공시 • Jan 21Transpek Industry Limited to Report Q3, 2026 Results on Feb 04, 2026Transpek Industry Limited announced that they will report Q3, 2026 results on Feb 04, 2026Reported Earnings • Nov 15Second quarter 2026 earnings released: EPS: ₹22.62 (vs ₹17.10 in 2Q 2025)Second quarter 2026 results: EPS: ₹22.62 (up from ₹17.10 in 2Q 2025). Revenue: ₹1.65b (up 1.6% from 2Q 2025). Net income: ₹126.4m (up 32% from 2Q 2025). Profit margin: 7.6% (up from 5.9% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.공시 • Nov 04Transpek Industry Limited to Report Q2, 2026 Results on Nov 13, 2025Transpek Industry Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 13, 2025Upcoming Dividend • Aug 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 August 2025. Payment date: 03 October 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.4%. Within top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%).New Risk • Aug 07New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.65b (US$98.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.3% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹8.65b market cap, or US$98.8m).Reported Earnings • Aug 06First quarter 2026 earnings released: EPS: ₹27.90 (vs ₹16.63 in 1Q 2025)First quarter 2026 results: EPS: ₹27.90 (up from ₹16.63 in 1Q 2025). Revenue: ₹1.66b (up 9.2% from 1Q 2025). Net income: ₹155.8m (up 68% from 1Q 2025). Profit margin: 9.4% (up from 6.1% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.공시 • Jul 23Transpek Industry Limited, Annual General Meeting, Sep 03, 2025Transpek Industry Limited, Annual General Meeting, Sep 03, 2025.공시 • Jul 22Transpek Industry Limited to Report Q1, 2026 Results on Aug 05, 2025Transpek Industry Limited announced that they will report Q1, 2026 results on Aug 05, 2025Reported Earnings • May 12Full year 2025 earnings released: EPS: ₹87.25 (vs ₹69.03 in FY 2024)Full year 2025 results: EPS: ₹87.25 (up from ₹69.03 in FY 2024). Revenue: ₹6.79b (up 16% from FY 2024). Net income: ₹487.4m (up 26% from FY 2024). Profit margin: 7.2% (up from 6.6% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.공시 • May 09Transpek Industry Limited Proposes DividendTranspek Industry Limited announced Board of Directors of the Company at its meeting held May 7, 2025 recommended and approved the dividend of INR 20/- (200%) per equity share on the face value of INR 10/- each which shall be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.New Risk • May 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.3% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.4% average weekly change). Profit margins are more than 30% lower than last year (5.5% net profit margin). Market cap is less than US$100m (₹6.99b market cap, or US$82.6m).Buy Or Sell Opportunity • May 08Now 33% overvaluedOver the last 90 days, the stock has fallen 4.7% to ₹1,501. The fair value is estimated to be ₹1,133, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 25%.공시 • Apr 28Transpek Industry Limited to Report Q4, 2025 Results on May 07, 2025Transpek Industry Limited announced that they will report Q4, 2025 results on May 07, 2025Buy Or Sell Opportunity • Apr 01Now 20% overvaluedOver the last 90 days, the stock has fallen 16% to ₹1,331. The fair value is estimated to be ₹1,108, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 25%.Reported Earnings • Feb 25Third quarter 2025 earnings released: EPS: ₹19.06 (vs ₹25.21 in 3Q 2024)Third quarter 2025 results: EPS: ₹19.06 (down from ₹25.21 in 3Q 2024). Revenue: ₹1.70b (up 15% from 3Q 2024). Net income: ₹106.0m (down 25% from 3Q 2024). Profit margin: 6.2% (down from 9.5% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.New Risk • Jan 27New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.51b (US$98.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.6% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.2% net profit margin). Market cap is less than US$100m (₹8.51b market cap, or US$98.6m).공시 • Jan 24Transpek Industry Limited to Report Q3, 2025 Results on Feb 10, 2025Transpek Industry Limited announced that they will report Q3, 2025 results on Feb 10, 2025Reported Earnings • Nov 18Second quarter 2025 earnings released: EPS: ₹17.10 (vs ₹5.40 in 2Q 2024)Second quarter 2025 results: EPS: ₹17.10 (up from ₹5.40 in 2Q 2024). Revenue: ₹1.68b (up 39% from 2Q 2024). Net income: ₹95.5m (up 218% from 2Q 2024). Profit margin: 5.7% (up from 2.5% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.공시 • Oct 30Transpek Industry Limited to Report Q2, 2025 Results on Nov 13, 2024Transpek Industry Limited announced that they will report Q2, 2025 results on Nov 13, 2024Buy Or Sell Opportunity • Oct 24Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to ₹1,469. The fair value is estimated to be ₹1,854, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Earnings per share has declined by 4.0%.New Risk • Oct 22New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.40b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.6% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹8.40b market cap, or US$99.9m).공시 • Oct 09Transpek Industry Limited Announces Demise of Shri Atul G. Shroff, DirectorTranspek Industry Limited was intimated on October 9, 2024 about the sad demise of Shri Atul G. Shroff, Director. Date of Cessation is October 9, 2024.공시 • Sep 25Transpek Industry Limited Approves Board AppointmentsTranspek Industry Limited at its AGM held on September 24, 2024 approved appointment of Shri Rajeev M. Pandia as an Independent Director; Shri Vijay S. Maniar as an Independent Director; Smt. Rita A. Teaotia as an Independent Director; Shri Maulik D. Mehta as an independent Director; Shri Ramkisan A. Devidayal as an Independent Director; Continuation of Directorship of Shri Ramkisan A. Devidayal Director.Upcoming Dividend • Sep 06Upcoming dividend of ₹14.00 per shareEligible shareholders must have bought the stock before 13 September 2024. Payment date: 24 October 2024. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.0%). Higher than average of industry peers (0.6%).공시 • Aug 12Transpek Industry Limited, Annual General Meeting, Sep 24, 2024Transpek Industry Limited, Annual General Meeting, Sep 24, 2024.Reported Earnings • Aug 09First quarter 2025 earnings released: EPS: ₹16.63 (vs ₹28.38 in 1Q 2024)First quarter 2025 results: EPS: ₹16.63 (down from ₹28.38 in 1Q 2024). Revenue: ₹1.63b (flat on 1Q 2024). Net income: ₹92.9m (down 41% from 1Q 2024). Profit margin: 5.7% (down from 9.8% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.공시 • Aug 08Transpek Industry Limited Announces Board ResignationsTranspek Industry Limited announced On the recommendations of the Nomination and Remuneration Committee at their meeting held on 7th August, 2024, the Board of Directors, at their Meeting held on 8 August, 2024, have taken the following decisions: Shri Ninad D. Gupte, Dr. Bernd Dill, Shri Nimish U. Patel, Smt. Geeta A. Goradia and Shri Hemant J. Bhatt having successfully completed 2 terms of 5 years each of being associated with the Company as independent Directors, shall retire from the office of Independent Directors with effect from close of business hours on 8th August, 2024, on account of completion of their tenure.공시 • Jul 29Transpek Industry Limited to Report Q1, 2025 Results on Aug 08, 2024Transpek Industry Limited announced that they will report Q1, 2025 results on Aug 08, 2024Buy Or Sell Opportunity • Jul 26Now 20% overvaluedOver the last 90 days, the stock has fallen 7.1% to ₹1,736. The fair value is estimated to be ₹1,447, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 11%.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,787, the stock trades at a trailing P/E ratio of 25.9x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 9.7% over the past three years.Buy Or Sell Opportunity • Jun 06Now 21% overvaluedOver the last 90 days, the stock has fallen 5.8% to ₹1,713. The fair value is estimated to be ₹1,419, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 11%.Reported Earnings • May 23Full year 2024 earnings released: EPS: ₹69.03 (vs ₹149 in FY 2023)Full year 2024 results: EPS: ₹69.03 (down from ₹149 in FY 2023). Revenue: ₹6.05b (down 28% from FY 2023). Net income: ₹385.6m (down 54% from FY 2023). Profit margin: 6.4% (down from 10.0% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.공시 • May 10Transpek Industry Limited to Report Q4, 2024 Results on May 21, 2024Transpek Industry Limited announced that they will report Q4, 2024 results on May 21, 2024Reported Earnings • Feb 14Third quarter 2024 earnings released: EPS: ₹25.21 (vs ₹44.26 in 3Q 2023)Third quarter 2024 results: EPS: ₹25.21 (down from ₹44.26 in 3Q 2023). Revenue: ₹1.53b (down 22% from 3Q 2023). Net income: ₹140.8m (down 43% from 3Q 2023). Profit margin: 9.2% (down from 13% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.공시 • Jan 30Transpek Industry Limited to Report Q3, 2024 Results on Feb 12, 2024Transpek Industry Limited announced that they will report Q3, 2024 results on Feb 12, 2024Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,068, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 29% over the past three years.Reported Earnings • Nov 30Second quarter 2024 earnings released: EPS: ₹5.40 (vs ₹35.78 in 2Q 2023)Second quarter 2024 results: EPS: ₹5.40 (down from ₹35.78 in 2Q 2023). Revenue: ₹1.25b (down 42% from 2Q 2023). Net income: ₹30.0m (down 85% from 2Q 2023). Profit margin: 2.4% (down from 9.2% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.공시 • Oct 28Transpek Industry Limited to Report Q2, 2024 Results on Nov 06, 2023Transpek Industry Limited announced that they will report Q2, 2024 results on Nov 06, 2023공시 • Aug 30Transpek Industry Limited Approves to Declare Dividend for the Year Ended 31.03.2023, Payable on or After 5 September, 2023Transpek Industry Limited announced at the AGM held on August 29, 2023, approved Dividend of INR 27.50/- per share (275%) was declared which is payable on or after 5th September, 2023.Upcoming Dividend • Aug 14Upcoming dividend of ₹27.50 per share at 1.4% yieldEligible shareholders must have bought the stock before 21 August 2023. Payment date: 28 September 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 1.4%. Within top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.9%).Reported Earnings • Aug 05Full year 2023 earnings released: EPS: ₹149 (vs ₹117 in FY 2022)Full year 2023 results: EPS: ₹149 (up from ₹117 in FY 2022). Revenue: ₹8.34b (up 38% from FY 2022). Net income: ₹834.8m (up 28% from FY 2022). Profit margin: 10.0% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.공시 • Aug 03Transpek Industry Limited Proposes to Declare Dividend for the Financial Year Ended 31St March, 2023Transpek Industry Limited proposed To declare Dividend on the equity shares of the Company for the financial year ended 31st March, 2023 Dividend at the rate of 275% i.e. INR 27.50/- (Rupees Twenty Seven and Paise Fifty Only) per Equity Share for the year ended 31st March, 2023, be and is hereby declared and the same be paid on 55,85,569 Equity Shares of INR 10/- (Rupees Ten only) each fully paid up, as recommended by the Board of Directors of the Company.공시 • Jul 30Transpek Industry Limited to Report Q1, 2024 Results on Aug 08, 2023Transpek Industry Limited announced that they will report Q1, 2024 results on Aug 08, 2023Reported Earnings • Jun 08Full year 2023 earnings released: EPS: ₹149 (vs ₹117 in FY 2022)Full year 2023 results: EPS: ₹149 (up from ₹117 in FY 2022). Revenue: ₹8.45b (up 40% from FY 2022). Net income: ₹835.0m (up 28% from FY 2022). Profit margin: 9.9% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 8% per year.공시 • May 19Transpek Industry Limited, Annual General Meeting, Aug 29, 2023Transpek Industry Limited, Annual General Meeting, Aug 29, 2023, at 15:00 Indian Standard Time. Agenda: To consider dividend.공시 • May 09Transpek Industry Limited to Report Q4, 2023 Results on May 18, 2023Transpek Industry Limited announced that they will report Q4, 2023 results on May 18, 2023Reported Earnings • Feb 16Third quarter 2023 earnings released: EPS: ₹44.26 (vs ₹30.69 in 3Q 2022)Third quarter 2023 results: EPS: ₹44.26 (up from ₹30.69 in 3Q 2022). Revenue: ₹2.00b (up 28% from 3Q 2022). Net income: ₹247.0m (up 44% from 3Q 2022). Profit margin: 12% (up from 11% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has remained flat.공시 • Feb 01Transpek Industry Limited to Report Q3, 2023 Results on Feb 08, 2023Transpek Industry Limited announced that they will report Q3, 2023 results on Feb 08, 2023Board Change • Dec 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 10 highly experienced directors. Joint MD & Whole-Time Director Avtar Singh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: ₹35.78 (vs ₹31.50 in 2Q 2022)Second quarter 2023 results: EPS: ₹35.78 (up from ₹31.50 in 2Q 2022). Revenue: ₹2.21b (up 39% from 2Q 2022). Net income: ₹199.9m (up 14% from 2Q 2022). Profit margin: 9.1% (down from 11% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.5% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.공시 • Nov 02Transpek Industry Limited to Report Q2, 2023 Results on Nov 09, 2022Transpek Industry Limited announced that they will report Q2, 2023 results on Nov 09, 2022Upcoming Dividend • Aug 29Upcoming dividend of ₹22.50 per shareEligible shareholders must have bought the stock before 05 September 2022. Payment date: 14 October 2022. Payout ratio is a comfortable 18% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.6%). Higher than average of industry peers (0.7%).공시 • Aug 02Transpek Industry Limited to Report Q1, 2023 Results on Aug 12, 2022Transpek Industry Limited announced that they will report Q1, 2023 results on Aug 12, 2022Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,683, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹1,464, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 5.0% over the past three years.공시 • May 20+ 1 more updateTranspek Industry Limited, Annual General Meeting, Sep 14, 2022Transpek Industry Limited, Annual General Meeting, Sep 14, 2022, at 15:00 Indian Standard Time.공시 • May 10Transpek Industry Limited to Report Q4, 2022 Results on May 19, 2022Transpek Industry Limited announced that they will report Q4, 2022 results on May 19, 2022Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹2,288, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.Recent Insider Transactions • Aug 30Insider recently sold ₹57m worth of stockOn the 26th of August, Chetna Saraiya sold around 28k shares on-market at roughly ₹2,042 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Upcoming Dividend • Aug 30Upcoming dividend of ₹7.50 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 15 October 2021. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%).Reported Earnings • Aug 11First quarter 2022 earnings released: EPS ₹24.21 (vs ₹6.74 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹1.32b (up 66% from 1Q 2021). Net income: ₹135.2m (up 259% from 1Q 2021). Profit margin: 10% (up from 4.7% in 1Q 2021). The increase in margin was driven by higher revenue.Reported Earnings • May 28Full year 2021 earnings released: EPS ₹41.74 (vs ₹131 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹3.57b (down 38% from FY 2020). Net income: ₹233.0m (down 68% from FY 2020). Profit margin: 6.5% (down from 13% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • May 22Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹1,607, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 28% over the past three years.Is New 90 Day High Low • Feb 12New 90-day low: ₹1,467The company is down 3.0% from its price of ₹1,514 on 14 November 2020. The Indian market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.공시 • Jan 29Transpek Industry Limited to Report Q3, 2021 Results on Feb 10, 2021Transpek Industry Limited announced that they will report Q3, 2021 results on Feb 10, 2021Is New 90 Day High Low • Nov 12New 90-day low: ₹1,501The company is down 1.0% from its price of ₹1,520 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS ₹1.03The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹802.5m (down 38% from 2Q 2020). Net income: ₹5.70m (down 96% from 2Q 2020). Profit margin: 0.7% (down from 12% in 2Q 2020). The decrease in margin was driven by lower revenue.공시 • Jul 26Transpek Industry Limited to Report Q1, 2021 Results on Aug 10, 2020Transpek Industry Limited announced that they will report Q1, 2021 results on Aug 10, 2020주주 수익률506687IN ChemicalsIN 시장7D-1.1%0.1%-1.2%1Y-42.8%-5.5%-5.1%전체 주주 수익률 보기수익률 대 산업: 506687은 지난 1년 동안 -5.5%의 수익을 기록한 Indian Chemicals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 506687은 지난 1년 동안 -5.1%를 기록한 Indian 시장보다 저조한 성과를 냈습니다.주가 변동성Is 506687's price volatile compared to industry and market?506687 volatility506687 Average Weekly Movement7.0%Chemicals Industry Average Movement7.2%Market Average Movement7.1%10% most volatile stocks in IN Market10.2%10% least volatile stocks in IN Market4.7%안정적인 주가: 506687는 지난 3개월 동안 Indian 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: 506687의 주간 변동성(7%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트1965574Bimal Mehtawww.transpek.com트랜스펙 인더스트리 리미티드는 인도에서 화학 제품을 제조 및 판매합니다. 2, 4, 6 트리메틸 벤조일 클로라이드, 2-클로로 에틸 아민 염산염 용액, 2-에틸 헥사 노일 클로라이드, 2- 메 톡시에틸 클로라이드, 2- 프로폭시에틸 클로라이드, 4- 클로로 부티릴 클로라이드, 코코 일 클로라이드, 디 에틸렌 글리콜 이염화, 이소 부틸 클로라이드, 이소 노나 노일 클로라이드, 이소프탈로일 염화물 및 로로 일 클로라이드를 제공합니다. 또한 m-니트로벤조일 클로라이드, 메톡시아세틸 클로라이드, n-부틸 클로라이드, n-데카노일 클로라이드, n-옥틸 클로라이드, n-발레로일 클로라이드, 네오데카노일 클로라이드, o-톨루오일 클로라이드도 공급합니다, 옥타노일 클로라이드, 염화 피니트로벤조일, 염화 피발로일, 염화 프로파르길 용액, 염화 이염화 황, 염화 일염화 황, 염화 테레프탈로일, 염화 트리에틸렌글리콜 및 염화 티오닐.더 보기Transpek Industry Limited 기초 지표 요약Transpek Industry의 순이익과 매출은 시가총액과 어떻게 비교됩니까?506687 기초 통계시가총액₹5.45b순이익 (TTM)₹456.45m매출 (TTM)₹6.21b11.9x주가수익비율(P/E)0.9x주가매출비율(P/S)506687는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표506687 손익계산서 (TTM)매출₹6.21b매출원가₹2.91b총이익₹3.31b기타 비용₹2.85b순이익₹456.45m최근 보고된 실적Mar 31, 2026다음 실적 발표일해당 없음주당순이익(EPS)81.72총이익률53.22%순이익률7.35%부채/자본 비율9.2%506687의 장기 실적은 어땠습니까?과거 실적 및 비교 보기배당2.1%현재 배당 수익률24%배당 성향View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/10 07:05종가2026/06/10 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Transpek Industry Limited는 3명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Nikhil ShettyBP Wealth Management Private LimitedKameswari V. S. ChavaliFirstCall ResearchVijay MadunalaFirstCall Research
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹999, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.
공시 • May 27Transpek Industry Limited Recommends Dividend for the Year Ended March 31, 2026Transpek Industry Limited at the board meeting held on May 26, 2026 recommended and approved the dividend of INR 20/- (200%) per equity share on the face value of INR 10/- each for the year ended March 31, 2026, which shall be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days of its declaration by the shareholders at the AGM to be held on September 15, 2026.
New Risk • May 27New major risk - Revenue and earnings growthEarnings have declined by 1.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.8% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹5.99b market cap, or US$62.5m).
공시 • May 18Transpek Industry Limited to Report Q4, 2026 Results on May 26, 2026Transpek Industry Limited announced that they will report Q4, 2026 results on May 26, 2026
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,056, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 32% over the past three years.
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: ₹19.42 (vs ₹19.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹19.42 (up from ₹19.06 in 3Q 2025). Revenue: ₹1.62b (down 4.7% from 3Q 2025). Net income: ₹108.5m (up 2.3% from 3Q 2025). Profit margin: 6.7% (up from 6.2% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 10% per year.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹999, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.
공시 • May 27Transpek Industry Limited Recommends Dividend for the Year Ended March 31, 2026Transpek Industry Limited at the board meeting held on May 26, 2026 recommended and approved the dividend of INR 20/- (200%) per equity share on the face value of INR 10/- each for the year ended March 31, 2026, which shall be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend will be paid within 30 days of its declaration by the shareholders at the AGM to be held on September 15, 2026.
New Risk • May 27New major risk - Revenue and earnings growthEarnings have declined by 1.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.8% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹5.99b market cap, or US$62.5m).
공시 • May 18Transpek Industry Limited to Report Q4, 2026 Results on May 26, 2026Transpek Industry Limited announced that they will report Q4, 2026 results on May 26, 2026
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹1,056, the stock trades at a trailing P/E ratio of 10.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 32% over the past three years.
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: ₹19.42 (vs ₹19.06 in 3Q 2025)Third quarter 2026 results: EPS: ₹19.42 (up from ₹19.06 in 3Q 2025). Revenue: ₹1.62b (down 4.7% from 3Q 2025). Net income: ₹108.5m (up 2.3% from 3Q 2025). Profit margin: 6.7% (up from 6.2% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year whereas the company’s share price has fallen by 10% per year.
공시 • Jan 21Transpek Industry Limited to Report Q3, 2026 Results on Feb 04, 2026Transpek Industry Limited announced that they will report Q3, 2026 results on Feb 04, 2026
Reported Earnings • Nov 15Second quarter 2026 earnings released: EPS: ₹22.62 (vs ₹17.10 in 2Q 2025)Second quarter 2026 results: EPS: ₹22.62 (up from ₹17.10 in 2Q 2025). Revenue: ₹1.65b (up 1.6% from 2Q 2025). Net income: ₹126.4m (up 32% from 2Q 2025). Profit margin: 7.6% (up from 5.9% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
공시 • Nov 04Transpek Industry Limited to Report Q2, 2026 Results on Nov 13, 2025Transpek Industry Limited announced that they will report Q2, 2026 results at 12:15 PM, Indian Standard Time on Nov 13, 2025
Upcoming Dividend • Aug 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 August 2025. Payment date: 03 October 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.4%. Within top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.7%).
New Risk • Aug 07New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.65b (US$98.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.3% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₹8.65b market cap, or US$98.8m).
Reported Earnings • Aug 06First quarter 2026 earnings released: EPS: ₹27.90 (vs ₹16.63 in 1Q 2025)First quarter 2026 results: EPS: ₹27.90 (up from ₹16.63 in 1Q 2025). Revenue: ₹1.66b (up 9.2% from 1Q 2025). Net income: ₹155.8m (up 68% from 1Q 2025). Profit margin: 9.4% (up from 6.1% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
공시 • Jul 23Transpek Industry Limited, Annual General Meeting, Sep 03, 2025Transpek Industry Limited, Annual General Meeting, Sep 03, 2025.
공시 • Jul 22Transpek Industry Limited to Report Q1, 2026 Results on Aug 05, 2025Transpek Industry Limited announced that they will report Q1, 2026 results on Aug 05, 2025
Reported Earnings • May 12Full year 2025 earnings released: EPS: ₹87.25 (vs ₹69.03 in FY 2024)Full year 2025 results: EPS: ₹87.25 (up from ₹69.03 in FY 2024). Revenue: ₹6.79b (up 16% from FY 2024). Net income: ₹487.4m (up 26% from FY 2024). Profit margin: 7.2% (up from 6.6% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
공시 • May 09Transpek Industry Limited Proposes DividendTranspek Industry Limited announced Board of Directors of the Company at its meeting held May 7, 2025 recommended and approved the dividend of INR 20/- (200%) per equity share on the face value of INR 10/- each which shall be subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.
New Risk • May 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.3% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.4% average weekly change). Profit margins are more than 30% lower than last year (5.5% net profit margin). Market cap is less than US$100m (₹6.99b market cap, or US$82.6m).
Buy Or Sell Opportunity • May 08Now 33% overvaluedOver the last 90 days, the stock has fallen 4.7% to ₹1,501. The fair value is estimated to be ₹1,133, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 25%.
공시 • Apr 28Transpek Industry Limited to Report Q4, 2025 Results on May 07, 2025Transpek Industry Limited announced that they will report Q4, 2025 results on May 07, 2025
Buy Or Sell Opportunity • Apr 01Now 20% overvaluedOver the last 90 days, the stock has fallen 16% to ₹1,331. The fair value is estimated to be ₹1,108, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 25%.
Reported Earnings • Feb 25Third quarter 2025 earnings released: EPS: ₹19.06 (vs ₹25.21 in 3Q 2024)Third quarter 2025 results: EPS: ₹19.06 (down from ₹25.21 in 3Q 2024). Revenue: ₹1.70b (up 15% from 3Q 2024). Net income: ₹106.0m (down 25% from 3Q 2024). Profit margin: 6.2% (down from 9.5% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
New Risk • Jan 27New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.51b (US$98.6m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.6% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (6.2% net profit margin). Market cap is less than US$100m (₹8.51b market cap, or US$98.6m).
공시 • Jan 24Transpek Industry Limited to Report Q3, 2025 Results on Feb 10, 2025Transpek Industry Limited announced that they will report Q3, 2025 results on Feb 10, 2025
Reported Earnings • Nov 18Second quarter 2025 earnings released: EPS: ₹17.10 (vs ₹5.40 in 2Q 2024)Second quarter 2025 results: EPS: ₹17.10 (up from ₹5.40 in 2Q 2024). Revenue: ₹1.68b (up 39% from 2Q 2024). Net income: ₹95.5m (up 218% from 2Q 2024). Profit margin: 5.7% (up from 2.5% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
공시 • Oct 30Transpek Industry Limited to Report Q2, 2025 Results on Nov 13, 2024Transpek Industry Limited announced that they will report Q2, 2025 results on Nov 13, 2024
Buy Or Sell Opportunity • Oct 24Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to ₹1,469. The fair value is estimated to be ₹1,854, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Earnings per share has declined by 4.0%.
New Risk • Oct 22New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.40b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.6% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (₹8.40b market cap, or US$99.9m).
공시 • Oct 09Transpek Industry Limited Announces Demise of Shri Atul G. Shroff, DirectorTranspek Industry Limited was intimated on October 9, 2024 about the sad demise of Shri Atul G. Shroff, Director. Date of Cessation is October 9, 2024.
공시 • Sep 25Transpek Industry Limited Approves Board AppointmentsTranspek Industry Limited at its AGM held on September 24, 2024 approved appointment of Shri Rajeev M. Pandia as an Independent Director; Shri Vijay S. Maniar as an Independent Director; Smt. Rita A. Teaotia as an Independent Director; Shri Maulik D. Mehta as an independent Director; Shri Ramkisan A. Devidayal as an Independent Director; Continuation of Directorship of Shri Ramkisan A. Devidayal Director.
Upcoming Dividend • Sep 06Upcoming dividend of ₹14.00 per shareEligible shareholders must have bought the stock before 13 September 2024. Payment date: 24 October 2024. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.0%). Higher than average of industry peers (0.6%).
공시 • Aug 12Transpek Industry Limited, Annual General Meeting, Sep 24, 2024Transpek Industry Limited, Annual General Meeting, Sep 24, 2024.
Reported Earnings • Aug 09First quarter 2025 earnings released: EPS: ₹16.63 (vs ₹28.38 in 1Q 2024)First quarter 2025 results: EPS: ₹16.63 (down from ₹28.38 in 1Q 2024). Revenue: ₹1.63b (flat on 1Q 2024). Net income: ₹92.9m (down 41% from 1Q 2024). Profit margin: 5.7% (down from 9.8% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year.
공시 • Aug 08Transpek Industry Limited Announces Board ResignationsTranspek Industry Limited announced On the recommendations of the Nomination and Remuneration Committee at their meeting held on 7th August, 2024, the Board of Directors, at their Meeting held on 8 August, 2024, have taken the following decisions: Shri Ninad D. Gupte, Dr. Bernd Dill, Shri Nimish U. Patel, Smt. Geeta A. Goradia and Shri Hemant J. Bhatt having successfully completed 2 terms of 5 years each of being associated with the Company as independent Directors, shall retire from the office of Independent Directors with effect from close of business hours on 8th August, 2024, on account of completion of their tenure.
공시 • Jul 29Transpek Industry Limited to Report Q1, 2025 Results on Aug 08, 2024Transpek Industry Limited announced that they will report Q1, 2025 results on Aug 08, 2024
Buy Or Sell Opportunity • Jul 26Now 20% overvaluedOver the last 90 days, the stock has fallen 7.1% to ₹1,736. The fair value is estimated to be ₹1,447, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 11%.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,787, the stock trades at a trailing P/E ratio of 25.9x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 9.7% over the past three years.
Buy Or Sell Opportunity • Jun 06Now 21% overvaluedOver the last 90 days, the stock has fallen 5.8% to ₹1,713. The fair value is estimated to be ₹1,419, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 11%.
Reported Earnings • May 23Full year 2024 earnings released: EPS: ₹69.03 (vs ₹149 in FY 2023)Full year 2024 results: EPS: ₹69.03 (down from ₹149 in FY 2023). Revenue: ₹6.05b (down 28% from FY 2023). Net income: ₹385.6m (down 54% from FY 2023). Profit margin: 6.4% (down from 10.0% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
공시 • May 10Transpek Industry Limited to Report Q4, 2024 Results on May 21, 2024Transpek Industry Limited announced that they will report Q4, 2024 results on May 21, 2024
Reported Earnings • Feb 14Third quarter 2024 earnings released: EPS: ₹25.21 (vs ₹44.26 in 3Q 2023)Third quarter 2024 results: EPS: ₹25.21 (down from ₹44.26 in 3Q 2023). Revenue: ₹1.53b (down 22% from 3Q 2023). Net income: ₹140.8m (down 43% from 3Q 2023). Profit margin: 9.2% (down from 13% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
공시 • Jan 30Transpek Industry Limited to Report Q3, 2024 Results on Feb 12, 2024Transpek Industry Limited announced that they will report Q3, 2024 results on Feb 12, 2024
Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹2,068, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 29% over the past three years.
Reported Earnings • Nov 30Second quarter 2024 earnings released: EPS: ₹5.40 (vs ₹35.78 in 2Q 2023)Second quarter 2024 results: EPS: ₹5.40 (down from ₹35.78 in 2Q 2023). Revenue: ₹1.25b (down 42% from 2Q 2023). Net income: ₹30.0m (down 85% from 2Q 2023). Profit margin: 2.4% (down from 9.2% in 2Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
공시 • Oct 28Transpek Industry Limited to Report Q2, 2024 Results on Nov 06, 2023Transpek Industry Limited announced that they will report Q2, 2024 results on Nov 06, 2023
공시 • Aug 30Transpek Industry Limited Approves to Declare Dividend for the Year Ended 31.03.2023, Payable on or After 5 September, 2023Transpek Industry Limited announced at the AGM held on August 29, 2023, approved Dividend of INR 27.50/- per share (275%) was declared which is payable on or after 5th September, 2023.
Upcoming Dividend • Aug 14Upcoming dividend of ₹27.50 per share at 1.4% yieldEligible shareholders must have bought the stock before 21 August 2023. Payment date: 28 September 2023. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 1.4%. Within top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.9%).
Reported Earnings • Aug 05Full year 2023 earnings released: EPS: ₹149 (vs ₹117 in FY 2022)Full year 2023 results: EPS: ₹149 (up from ₹117 in FY 2022). Revenue: ₹8.34b (up 38% from FY 2022). Net income: ₹834.8m (up 28% from FY 2022). Profit margin: 10.0% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
공시 • Aug 03Transpek Industry Limited Proposes to Declare Dividend for the Financial Year Ended 31St March, 2023Transpek Industry Limited proposed To declare Dividend on the equity shares of the Company for the financial year ended 31st March, 2023 Dividend at the rate of 275% i.e. INR 27.50/- (Rupees Twenty Seven and Paise Fifty Only) per Equity Share for the year ended 31st March, 2023, be and is hereby declared and the same be paid on 55,85,569 Equity Shares of INR 10/- (Rupees Ten only) each fully paid up, as recommended by the Board of Directors of the Company.
공시 • Jul 30Transpek Industry Limited to Report Q1, 2024 Results on Aug 08, 2023Transpek Industry Limited announced that they will report Q1, 2024 results on Aug 08, 2023
Reported Earnings • Jun 08Full year 2023 earnings released: EPS: ₹149 (vs ₹117 in FY 2022)Full year 2023 results: EPS: ₹149 (up from ₹117 in FY 2022). Revenue: ₹8.45b (up 40% from FY 2022). Net income: ₹835.0m (up 28% from FY 2022). Profit margin: 9.9% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 8% per year.
공시 • May 19Transpek Industry Limited, Annual General Meeting, Aug 29, 2023Transpek Industry Limited, Annual General Meeting, Aug 29, 2023, at 15:00 Indian Standard Time. Agenda: To consider dividend.
공시 • May 09Transpek Industry Limited to Report Q4, 2023 Results on May 18, 2023Transpek Industry Limited announced that they will report Q4, 2023 results on May 18, 2023
Reported Earnings • Feb 16Third quarter 2023 earnings released: EPS: ₹44.26 (vs ₹30.69 in 3Q 2022)Third quarter 2023 results: EPS: ₹44.26 (up from ₹30.69 in 3Q 2022). Revenue: ₹2.00b (up 28% from 3Q 2022). Net income: ₹247.0m (up 44% from 3Q 2022). Profit margin: 12% (up from 11% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has remained flat.
공시 • Feb 01Transpek Industry Limited to Report Q3, 2023 Results on Feb 08, 2023Transpek Industry Limited announced that they will report Q3, 2023 results on Feb 08, 2023
Board Change • Dec 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 1 experienced director. 10 highly experienced directors. Joint MD & Whole-Time Director Avtar Singh was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: ₹35.78 (vs ₹31.50 in 2Q 2022)Second quarter 2023 results: EPS: ₹35.78 (up from ₹31.50 in 2Q 2022). Revenue: ₹2.21b (up 39% from 2Q 2022). Net income: ₹199.9m (up 14% from 2Q 2022). Profit margin: 9.1% (down from 11% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.5% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
공시 • Nov 02Transpek Industry Limited to Report Q2, 2023 Results on Nov 09, 2022Transpek Industry Limited announced that they will report Q2, 2023 results on Nov 09, 2022
Upcoming Dividend • Aug 29Upcoming dividend of ₹22.50 per shareEligible shareholders must have bought the stock before 05 September 2022. Payment date: 14 October 2022. Payout ratio is a comfortable 18% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.6%). Higher than average of industry peers (0.7%).
공시 • Aug 02Transpek Industry Limited to Report Q1, 2023 Results on Aug 12, 2022Transpek Industry Limited announced that they will report Q1, 2023 results on Aug 12, 2022
Valuation Update With 7 Day Price Move • Jun 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹1,683, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 22% over the past three years.
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹1,464, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 5.0% over the past three years.
공시 • May 20+ 1 more updateTranspek Industry Limited, Annual General Meeting, Sep 14, 2022Transpek Industry Limited, Annual General Meeting, Sep 14, 2022, at 15:00 Indian Standard Time.
공시 • May 10Transpek Industry Limited to Report Q4, 2022 Results on May 19, 2022Transpek Industry Limited announced that they will report Q4, 2022 results on May 19, 2022
Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹2,288, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.
Recent Insider Transactions • Aug 30Insider recently sold ₹57m worth of stockOn the 26th of August, Chetna Saraiya sold around 28k shares on-market at roughly ₹2,042 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Upcoming Dividend • Aug 30Upcoming dividend of ₹7.50 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 15 October 2021. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.7%).
Reported Earnings • Aug 11First quarter 2022 earnings released: EPS ₹24.21 (vs ₹6.74 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹1.32b (up 66% from 1Q 2021). Net income: ₹135.2m (up 259% from 1Q 2021). Profit margin: 10% (up from 4.7% in 1Q 2021). The increase in margin was driven by higher revenue.
Reported Earnings • May 28Full year 2021 earnings released: EPS ₹41.74 (vs ₹131 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹3.57b (down 38% from FY 2020). Net income: ₹233.0m (down 68% from FY 2020). Profit margin: 6.5% (down from 13% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • May 22Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹1,607, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 28% over the past three years.
Is New 90 Day High Low • Feb 12New 90-day low: ₹1,467The company is down 3.0% from its price of ₹1,514 on 14 November 2020. The Indian market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.
공시 • Jan 29Transpek Industry Limited to Report Q3, 2021 Results on Feb 10, 2021Transpek Industry Limited announced that they will report Q3, 2021 results on Feb 10, 2021
Is New 90 Day High Low • Nov 12New 90-day low: ₹1,501The company is down 1.0% from its price of ₹1,520 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Reported Earnings • Nov 11Second quarter 2021 earnings released: EPS ₹1.03The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹802.5m (down 38% from 2Q 2020). Net income: ₹5.70m (down 96% from 2Q 2020). Profit margin: 0.7% (down from 12% in 2Q 2020). The decrease in margin was driven by lower revenue.
공시 • Jul 26Transpek Industry Limited to Report Q1, 2021 Results on Aug 10, 2020Transpek Industry Limited announced that they will report Q1, 2021 results on Aug 10, 2020
